Skip to main content
logo
VitaSpring Biomedical Co. Ltd. (VSBC)
OTCMKTS · Delayed Price · Currency is USD
0.0111
-0.2390 (-95.56%)
At close: Feb 12, 2026

VitaSpring Biomedical Ratios and Metrics

Millions USD. Fiscal year is Feb - Jan.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Market Capitalization
252313,1053,0832,891
Market Cap Growth
-92.60%66.73%-99.00%0.72%6.64%296.72%
Enterprise Value
252313,1063,0842,892
Last Close Price
0.010.250.1515.0014.9314.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
PE Ratio
-----3178.77
PS Ratio
-----515.09
PB Ratio
-0.51-11.69-7.73-926.95-1286.611832.78
P/TBV Ratio
-----1832.78

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
EV/Sales Ratio
-----515.14
EV/EBITDA Ratio
-----2547.59
EV/EBIT Ratio
-----2566.49

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Debt / Equity Ratio
----0.03-0.110.29
Debt / EBITDA Ratio
-----0.38
Net Debt / Equity Ratio
0.0000-0.02-0.100.23
Net Debt / EBITDA Ratio
0.020.010-0.06-0.060.31
Net Debt / FCF Ratio
-1.950.780.02-2.00-3.01-1.04
Asset Turnover
-----2.96
Quick Ratio
0.00000.010.131.76
Current Ratio
0.000.0000.010.141.76
Return on Equity (ROE)
-----108.68%
Return on Assets (ROA)
-2096.65%-1655.78%-560.17%-153.34%-119.50%37.13%
Return on Invested Capital (ROIC)
-----91.65%
Return on Capital Employed (ROCE)
8.70%8.70%16.90%33.10%181.40%60.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Earnings Yield
-17.87%-0.80%-2.50%-0.04%-0.14%0.03%
FCF Yield
0.18%-0.01%-0.05%-0.00%-0.00%-0.01%
Buyback Yield / Dilution
----0.25%-0.26%-126.13%